This event was organized by the Foundation of the Society for the Study of Neuroprotection and Neuroplasticity, together with the Romanian Society of Neurology and “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania. It was endorsed by the World Federation of Neurorehabilitation (WFNR), the European Federation of Neurorehabilitation Societies (EFNR) and the EAN.

by Amaia Muñoz Lopetegi I am truly satisfied with the fellowship experience, which has been absolutely enriching for my professional and personal development as a neurologist, both in the clinical side and in research.   I am quite happy with… Continue Reading

The BioMed Alliance through the work of its Task Force “Clinical Trials” published a statement on the need for Europe to implement patient-centered clinical research.     Precision medicine approaches the treatment of disease via an individual’s genes, environment, and… Continue Reading

          by Anna Sauerbier         European Brain Council provides feedback on the Horizon Europe proposals http://www.braincouncil.eu/activities/news/ebc-provides-feedback-on-the-horizon-europe-proposals/   The FDA designates device aiming to mitigate symptoms of agitation and depression associated with AD as… Continue Reading

In 2 weeks, my sabbatical period in the United States, which started in April 2018, will come to an end. The word sabbatical comes from “Sabbath,” which in the biblical Old Testament was described as, “In the seventh year the land shall have a Sabbath of complete rest …” Today in Academics, it is obviously not simply rest. For me it was a break after 23 years of an uninterrupted hospital and university activity, 17 of which as chair or vice-chair of large neurological departments.

This is the Land of Fire and the Pearl of the Caucasus, a land where eastern colors combine magnificently with western progress. Azerbaijan is situated at the eastern side of the Transcaucasia on the shores of the Caspian Sea. The… Continue Reading

For September 2018, we have selected:  Katzenschlager R, Poewe W, Rascol O, et al. Apomorphine subcutaneous infusion in patients with Parkinson’s disease with persisten motor fluctuations (TOLEDO): a multicenter, double-blind, randomized, placebo-controlled trial. Lancet Neurol July 25, 2018. doi:10.1016/S1474-4422(18)30284-4. Subcutaneous infusion of apomorphine, a potent dopamine receptor agonist, is widely used in patients with Parkinson’s disease (PD) with motor fluctuations not optimally controlled with oral medication, but the previous evidence base to support this approach was weak, derived from open label studies.

2-5 JULY 2018, EFORIE NORD, ROMANIA As it is tradition, the 2018 edition of the International Summer School of Neurology was held in the resort on the Black Sea coast, Eforie Nord, Romania.

Manel  Ben Hmidene Ep Tezeghdenti, Ben Arous, Tunisia Term of the stay: 6 weeks

Are you already skilled at, or interested in learning how to review and write good Single Best Answer (SBA, multiple choice) questions? The EAN Education committee is seeking expressions of interest from anyone in the European neurology community to support… Continue Reading

The latest CME article August 2018: “Syndrome and outcome of antibody-negative limbic encephalitis” is online! Please log-in and browse to the LEARN section on the EAN Website and answer the questions! All e-learning activities are free-of-charge for EAN registered users.… Continue Reading

We would like to congratulate the winners of this year’s Investigator Award. The chosen winners have presented their work at the 4th EAN Congress in Lisbon this June. The Investigator Award consists of a free registration to the 5th EAN… Continue Reading

            by Anna Sauerbier         EFNA’s Survey of Young Europeans with Neurological Conditions https://www.efna.net/wp-content/uploads/2018/07/EFNAYoungPeopleSurvey.pdf   Two years after Brexit vote, a cloud still hangs over research https://sciencebusiness.net/news/two-years-after-brexit-vote-cloud-still-hangs-over-research   Societal Impact of Pain… Continue Reading

he Congress will begin each morning and afternoon with Plenary Sessions providing overviews of the phenomenology, pathophysiology, and current diagnostic and therapeutic strategies of various movement disorders. These sessions will be followed by Parallel Tracks, permitting participants to select specific diagnostic or therapeutic areas for more concentrated study.

RRFS special session: “Meet the experts and learn about clinical work and research (clinical and laboratory) around Europe” The special session of RRFS took place on Sunday, 17.06.2018 during the 4th EAN congress in Lisbon. The special session was held… Continue Reading